Corinne Jenkins
Stock Analyst at Goldman Sachs
(1.36)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GERN Geron | Reinstates: Sell | 1 | 1.35 | -25.93% | 4 | Jul 10, 2025 | |
RYTM Rhythm Pharmaceutica... | Maintains: Strong Buy | 59 66 | 94.32 | -30.03% | 8 | Dec 5, 2024 | |
TGTX TG Therapeutics | Maintains: Neutral | 20 22 | 26.4 | -16.67% | 8 | Nov 5, 2024 | |
ITCI Intra-Cellular Thera... | Maintains: Neutral | 77 74 | 131.87 | -43.88% | 5 | Aug 8, 2024 | |
FULC Fulcrum Therapeutics | Upgrades: Buy | 6 15 | 6.35 | 136.22% | 2 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 53 46 | 22.84 | 101.4% | 5 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 18 | 11.18 | 61% | 5 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 13 | 3.38 | 284.62% | 3 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 25 28 | 34.83 | -19.61% | 7 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 47 52 | 46.99 | 10.66% | 5 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 9 | 28 | -67.86% | 5 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 332 296 | 329.83 | -10.26% | 2 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 192 64 | 6.36 | 906.29% | 6 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 216 184 | 9.45 | 1847.09% | 2 | Mar 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 21 | 1.64 | 1180.49% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 14 | 6.3 | 122.22% | 2 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 2 | n/a | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 9 8 | 30 | -73.33% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 16 | n/a | n/a | 2 | Dec 15, 2021 |